Apimeds Pharma 10-Q Filing
Apimeds Pharmaceuticals US, Inc. files quarterly report with SEC. The report provides financial updates and operational insights.
Filed: 2026-05-26 AccNo: 0001213900-26-061013 Size: 4 MB
Apimeds Pharmaceuticals US, Inc. files quarterly report with SEC. The report provides financial updates and operational insights.
Filed: 2026-05-26 AccNo: 0001213900-26-061013 Size: 4 MB